Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2023 · 10-Q
Revenue$38.80M$38.80M+14.4% vs Q3 2022 Net Income-$4.26M-$4.26MN/M vs Q3 2022 EPS Diluted-$0.01-$0.01N/M vs Q3 2022 Gross Profit$16,838,000+4.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,900,000+136.2% Free Cash Flowderived$1,937,000+59.6% Margins · derivedGross margin43.4%−4.3 pt vs Q3 2022
Operating margin8.5%−8.4 pt vs Q3 2022
Net margin-11.0%−19.0 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end